Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000177825 | SCV000229765 | benign | not specified | 2015-05-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001704848 | SCV000523515 | likely benign | not provided | 2021-11-04 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000634660 | SCV000755994 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444710 | SCV002735061 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2020-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000177825 | SCV004038894 | benign | not specified | 2023-08-10 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001704848 | SCV005262447 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003967427 | SCV004781245 | likely benign | COL5A2-related disorder | 2021-05-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |